Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn Webster

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Pain Medicine (Malden, Mass.)|July 23, 2003
Modafinil treatment of opioid-induced sedationLynn Webster, Megan Andrews, Gregory Stoddard
Pain Medicine (Malden, Mass.)|April 13, 2011
Long-term safety of Remoxy® (extended-release oxycodone) in patients with moderate to severe chronic osteoarthritis or low back painNadav Friedmann, Vicki Klutzaritz, Lynn Webster
Journal of Opioid Management|April 27, 2022
Effects of buprenorphine buccal film and oral oxycodone on pupil diameter in a respiratory studyLynn Webster, Jacqueline Cater, Thomas Smith
Journal of Opioid Management|October 25, 2023
Three recent court decisions reframe what constitutes criminal conduct in prescribing controlled substancesLynn Webster, Olivia Backhaus, Amy Bianco
HERD|December 18, 2010
Evaluating building performance in healthcare facilities: an organizational perspectiveClaudia Steinke, Lynn Webster, Marie Fontaine
Journal of Opioid Management|August 10, 2011
Efficacy and safety of an extended-release oxycodone (Remoxy) formulation in patients with moderate to severe osteoarthritic painNadav Friedmann, Vicki Klutzaritz, Lynn Webster
Pain Medicine (Malden, Mass.)|September 25, 2012
American Academy of Pain Medicine response to PROP petition to the FDA that seeks to limit pain medications for legitimate noncancer pain sufferersPerry Fine, Lynn Webster, Charles Argoff
Pain Medicine (Malden, Mass.)|January 17, 2013
Response to letter by Dr. RuanBeatrice Setnik, Carl L Roland, Lynn Webster
Pain Management|March 21, 2014
Pseudoaddiction revisited: a commentary on clinical and historical considerationsSteven D Passik, Kenneth L Kirsh, Lynn Webster
Journal of Opioid Management|January 7, 2017
A 12-week extension study to assess the safety and tolerability of naloxegol in patients with noncancer pain and opioid-induced constipationLynn Webster, Raj Tummala, Ulysses Diva, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Pain Medicine (Malden, Mass.)|July 23, 2003
Modafinil treatment of opioid-induced sedationLynn Webster, Megan Andrews, Gregory Stoddard
Pain Medicine (Malden, Mass.)|April 13, 2011
Long-term safety of Remoxy® (extended-release oxycodone) in patients with moderate to severe chronic osteoarthritis or low back painNadav Friedmann, Vicki Klutzaritz, Lynn Webster
Journal of Opioid Management|April 27, 2022
Effects of buprenorphine buccal film and oral oxycodone on pupil diameter in a respiratory studyLynn Webster, Jacqueline Cater, Thomas Smith
Journal of Opioid Management|October 25, 2023
Three recent court decisions reframe what constitutes criminal conduct in prescribing controlled substancesLynn Webster, Olivia Backhaus, Amy Bianco
HERD|December 18, 2010
Evaluating building performance in healthcare facilities: an organizational perspectiveClaudia Steinke, Lynn Webster, Marie Fontaine
Journal of Opioid Management|August 10, 2011
Efficacy and safety of an extended-release oxycodone (Remoxy) formulation in patients with moderate to severe osteoarthritic painNadav Friedmann, Vicki Klutzaritz, Lynn Webster
Pain Medicine (Malden, Mass.)|September 25, 2012
American Academy of Pain Medicine response to PROP petition to the FDA that seeks to limit pain medications for legitimate noncancer pain sufferersPerry Fine, Lynn Webster, Charles Argoff
Pain Medicine (Malden, Mass.)|January 17, 2013
Response to letter by Dr. RuanBeatrice Setnik, Carl L Roland, Lynn Webster
Pain Management|March 21, 2014
Pseudoaddiction revisited: a commentary on clinical and historical considerationsSteven D Passik, Kenneth L Kirsh, Lynn Webster
Journal of Opioid Management|January 7, 2017
A 12-week extension study to assess the safety and tolerability of naloxegol in patients with noncancer pain and opioid-induced constipationLynn Webster, Raj Tummala, Ulysses Diva, et al.
Pageof 8